Biopharmas raising money in public or private financings, including: Cellectis, Curevac, Fortress, Kinsea, Longboard, Mediwound, Relief, Sonnet, Structure.

New hires and promotions in the biopharma industry, including: Allosteric, Carisma, Cour, Enplusone, Immpact, Immunome, Larimar, Merck, Micurx, Moma, Ovid, Palisade, T-knife.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Astellas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AI Medical Technology.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dia Imaging Analysis, Northeast Scientific, Vero Biotech.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arima, Avania, Carestream, Cytek, Imperative Care, Kandu Health, Nec, Maxis, Newtopia, Medtronic Canada, Pierian, Rhythm Management Group.

New hires and promotions in the med-tech industry, including: Biosig, Corentec, Cranius, Elevai Labs, Qosina, Upstream Bio.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abbisko, Alpha, Arcturus, Ascletis, Eisai, Greenlight, Help, Huidagene, Junshi, Mesoblast, Pfizer, Pharmala, Zai Lab.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Carsgen, Cidara, Healion, Qurient, Roche, TB Alliance, Tonix, Wuxi XDC, Ymmunobio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biophytis, Daiichi Sankyo, Ocumension, Oricell, Qurient, Sciwind.